Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey
Related Posts
Peng TJ, Schwamm LH, Fonarow GC, Hassan AE, Hill M, Messé SR, Coronado F, Falcone GJ, Sharma R. Contemporary Prestroke Dual Antiplatelet Use and Symptomatic[...]
Vaghefi E, Squirrell D, Yang S, An S, Xie L, Durbin MK, Hou H, Marshall J, Shreibati J, McConnell MV, Budoff M. Development and validation[...]
Hu S, Chapski DJ, Gehred ND, Kimball TH, Gromova T, Flores A, Rowat AC, Chen J, Packard RRS, Olszewski E, Davis J, Rau CD, McKinsey[...]